ScreenerHero

EXPRS2 ExpreS2ion Biotech Holding AB (publ)

STO · SE · Healthcare · Biotechnology · expres2ionbio.com
1.060SEK-5.78%Mkt Cap: 1.00M $P/E: —

ExpreS2ion Biotech Holding AB (publ), a clinical-stage biotechnology company, develops protein-based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally. The company's lea…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap1.00M USD
Enterprise Value-593.85K USD
Revenue (TTM)2.32M USD
Gross Profit13.10K USD
Net Income (TTM)-3.64M USD
Revenue/Share1.02 SEK
Last Price1.060 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees19
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0008348262
Valuation
P/E (Trailing)—
P/E (Forward)-0.05
PEG—
EV/EBITDA0.15
EV/Revenue-0.26
P/S0.46
P/B0.64
EPS (TTM)-4.35
EPS (Forward)-22.39
52W Range
1.0400% of range22.85
52W High22.85 SEK
52W Low1.040 SEK
Profitability
Gross Margin3.75%
Oper. Margin-103.68%
EBITDA Margin-175.79%
Profit Margin-1041.43%
ROE-106.72%
ROA-58.50%
Growth
Revenue Growth237.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.91M USD
CapEx (TTM)—
FCF Margin-168.66%
FCF Yield-390.34%
Net Debt-3.15M USD
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity0.04
Current Ratio3.38
Quick Ratio3.32
Book Value/Sh1.76 SEK
Cash/Share1.45 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateOct 30, 2024
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.000 SEK
Upside (mean)+371.7%
Target Range5.000 SEK – 5.000 SEK
# Analysts1
Ownership
Shares Out.9.88M
Float23.26M
Insiders0.00%
Institutions0.00%
Technical
SMA 501.317 (-19.5%)
SMA 2005.296 (-80.0%)
Beta2.21
S&P 52W Chg16.45%
Avg Vol (30d)73.66K
Avg Vol (10d)70.97K
Technical Indicators
RSI (14)33.8
MACD-0.0625
MACD Signal-0.0559
MACD Hist.-0.0066
BB Upper1.362 SEK
BB Middle1.197 SEK
BB Lower1.032 SEK
BB Width27.54%
ATR (14)0.0904 SEK
Vol Ratio (20d)0.44x